Venu Bathini
Overview
Explore the profile of Venu Bathini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bai S, Lindberg J, Whalen G, Bathini V, Zou J, Yang M
Am J Cancer Res
. 2021 Apr;
11(3):858-865.
PMID: 33791159
Pancreatic ductal adenocarcinoma (PDAC) represents one of the most common cancers with dismal prognosis. Definitive diagnosis of PDAC remains challenging due to the lack of specific biomarkers. A transcription factor...
2.
Zhu X, Jamshed S, Zou J, Azar A, Meng X, Bathini V, et al.
Mod Pathol
. 2021 Jan;
34(5):1017-1030.
PMID: 33483624
Squamous cell carcinoma (SqCC) is the most common malignancy of the anal canal, where it is strongly associated with HPV infection. Characteristic genomic alterations have been identified in anal SqCC,...
3.
Philip P, Lacy J, Portales F, Sobrero A, Pazo-Cid R, Manzano Mozo J, et al.
Lancet Gastroenterol Hepatol
. 2020 Jan;
5(3):285-294.
PMID: 31953079
Background: Treatment options for patients with unresectable locally advanced pancreatic cancer are scarce. Results from a subanalysis of the phase 3 MPACT trial in metastatic pancreatic cancer suggested potential activity...
4.
Al-Mansour Z, Pang L, Bathini V
Drugs Aging
. 2018 Nov;
36(1):1-11.
PMID: 30478744
With the worldwide trend of aging populations, the number of older adults who develop and survive cancer is likely to increase. In the last decade, oncology drug development has shifted...
5.
Zhu X, Salhab M, Tomaszewicz K, Meng X, Mathew C, Bathini V, et al.
Hum Pathol
. 2018 Nov;
85:260-269.
PMID: 30458197
The eighth edition of American Joint Committee on Cancer (AJCC) advocates a 3-tier grading system for appendiceal mucinous tumors. The mutational profile for each tumor grade and the impact of...
6.
Furtado V, Saini N, Walsh W, Bathini V, Miron P
Mol Cytogenet
. 2018 Nov;
11:56.
PMID: 30377450
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia recognizes a distinct class of myeloid and lymphoid tumors with eosinophilia-related proliferations associated with specific...
7.
8.
Kodali S, Bathini V, Rava P, Tipirneni E
J Gastrointest Cancer
. 2016 Jan;
48(1):66-69.
PMID: 26744322
No abstract available.
9.
Cetin V, Piperdi B, Bathini V, Walsh W, Yunus S, Tseng J, et al.
Gastrointest Cancer Res
. 2013 Dec;
6(4 Suppl 1):S2-9.
PMID: 24312684
Background: Pancreatic cancer is the fourth leading cause of cancer deaths in the United States. A minority of patients present with localized disease and surgical resection still offers patients the...
10.
Piperdi B, Walsh W, Bradley K, Zhou Z, Bathini V, Hanrahan-Boshes M, et al.
J Thorac Oncol
. 2012 Apr;
7(6):1032-40.
PMID: 22534815
Background: This study aimed to establish the maximum tolerated dose (MTD) of weekly bortezomib in combination with fixed standard doses of carboplatin and bevacizumab, and to estimate the efficacy (response...